Search research articles
Contact Us
Filters
Showing results (41-50 of 87) with videos related to
Page
of 9
Sort By:
Ejhaem
|
December 5, 2022
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia
Darcy B Pooler, Dylan B Ness, Alexey V Danilov, et al.
Journal of Cutaneous Pathology
|
July 16, 2022
Primary cutaneous gamma-delta T-cell lymphoma masquerading as leukemia cutis in a patient recently diagnosed with small lymphocytic lymphoma: Clues to the diagnosis
Koorosh Haghayeghi, Dhrumil Patel, Shauna M Rice, et al.
Leukemia Research Reports
|
June 18, 2021
Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice
Landis R Walsh, Chaofan Yuan, James T Boothe, et al.
British Journal of Haematology
|
July 6, 2016
A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities
Alexey V Danilov, Lionel D Lewis, Frederick Lansigan, et al.
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association
|
February 11, 2018
Goal Attainment and Goal Adjustment of Older Adults During Person-Directed Cancer Rehabilitation
Kathleen Doyle Lyons, Robin M Newman, Peter A Kaufman, et al.
Journal of Cutaneous Pathology
|
March 8, 2018
Tumor-stage mycosis fungoides in palmoplantar localization with large-cell transformation and partial CD30 expression shows complete response to brentuximab vedotin
Anh Khoa Pham, Joi B Carter, Nora R Ratcliffe, et al.
The American Journal of Surgical Pathology
|
May 29, 2026
TRBC1 Immunohistochemistry Utilization in Formalin-fixed Paraffin-embedded Tissue as an Adjunct to T-cell Clonality Testing in the Assessment of Cutaneous Lymphoproliferative Disorders
David G Grand, Jeffrey M Cloutier, Sarah R Palmer-DeClara, et al.
Cancer Research Communications
|
August 31, 2023
A Survey of Cancer Risk Behaviors, Beliefs, and Social Drivers of Health in New Hampshire and Vermont
Thomas A Skipper, Julie E Weiss, Heather A Carlos, et al.
Cancer Medicine
|
December 22, 2018
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
Frederick Lansigan, Ian Barak, Brandelyn Pitcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2019
Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe)
Frederick Lansigan, Cristiana A Costa, Bassem I Zaki, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 87) with videos related to
Sort By:
Page
of 9
Ejhaem
|
December 5, 2022
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia
Darcy B Pooler, Dylan B Ness, Alexey V Danilov, et al.
Journal of Cutaneous Pathology
|
July 16, 2022
Primary cutaneous gamma-delta T-cell lymphoma masquerading as leukemia cutis in a patient recently diagnosed with small lymphocytic lymphoma: Clues to the diagnosis
Koorosh Haghayeghi, Dhrumil Patel, Shauna M Rice, et al.
Leukemia Research Reports
|
June 18, 2021
Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice
Landis R Walsh, Chaofan Yuan, James T Boothe, et al.
British Journal of Haematology
|
July 6, 2016
A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities
Alexey V Danilov, Lionel D Lewis, Frederick Lansigan, et al.
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association
|
February 11, 2018
Goal Attainment and Goal Adjustment of Older Adults During Person-Directed Cancer Rehabilitation
Kathleen Doyle Lyons, Robin M Newman, Peter A Kaufman, et al.
Journal of Cutaneous Pathology
|
March 8, 2018
Tumor-stage mycosis fungoides in palmoplantar localization with large-cell transformation and partial CD30 expression shows complete response to brentuximab vedotin
Anh Khoa Pham, Joi B Carter, Nora R Ratcliffe, et al.
The American Journal of Surgical Pathology
|
May 29, 2026
TRBC1 Immunohistochemistry Utilization in Formalin-fixed Paraffin-embedded Tissue as an Adjunct to T-cell Clonality Testing in the Assessment of Cutaneous Lymphoproliferative Disorders
David G Grand, Jeffrey M Cloutier, Sarah R Palmer-DeClara, et al.
Cancer Research Communications
|
August 31, 2023
A Survey of Cancer Risk Behaviors, Beliefs, and Social Drivers of Health in New Hampshire and Vermont
Thomas A Skipper, Julie E Weiss, Heather A Carlos, et al.
Cancer Medicine
|
December 22, 2018
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
Frederick Lansigan, Ian Barak, Brandelyn Pitcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2019
Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe)
Frederick Lansigan, Cristiana A Costa, Bassem I Zaki, et al.
Page
of 9